NCT05610683View on ClinicalTrials.gov

Comparison of the Removal of Uremic Toxins With Medium Cut-off and Super High-flux Vitamin E-coated Dialyzers

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

June 14, 2023

Primary Completion Date

January 31, 2024

Study Completion Date

January 31, 2024

Conditions
End Stage Renal Disease (ESRD)
Interventions
DEVICE

Hemodialysis sessions using SHFVE dialyzer (VieX™) or the MCO (Theranova 500™) dialyzer

Patients will receive thrice weekly 4 hours hemodialysis sessions during 3 months

Trial Locations (1)

86000

CHU de Poitiers, Poitiers

Sponsors

Collaborators (1)

Hemotech
All Listed Sponsors
collaborator

Hemotech

INDUSTRY

lead

Poitiers University Hospital

OTHER